EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

“I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania

Daima Bukini, Kassim Kassim, Collins Kanza, Aisha Rifai, Rahma Chanzi, Augostino Amando, Elianna Amin, Jonathan Spector, Julie Makani

Public Health Genomics · 07.07.2026 · 29 (1) · 257-268

DOI: 10.1159/000551690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Genomics, online erschienen am 07.07.2026. Verfasst von Daima Bukini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, …. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Patient Acceptance of Health Care. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

While curative treatments for sickle cell disease (SCD), including hematopoietic stem cell transplant and gene therapies, are largely restricted to high-resource settings, recent advancements have raised hopes that they will eventually become more accessible to patients in Africa, where the disease is particularly prominent and contributes to substantial morbidity and mortality. Understanding the factors that influence acceptability of curative therapies will therefore be important in developing strategies for successful adoption and implementation.

Methods

To address this need, a qualitative study was conducted to gain insights into the perspectives of patients and families in Tanzania regarding curative therapies for SCD, focusing on factors affecting treatment acceptability. A total of 81 individuals (46 caregivers and 35 patients) participated in focus group discussions or in-depth interviews; the majority were female (67%) and between 21 and 40 years of age.

Results

The results indicated substantial interest in current and prospective curative programs, with various factors influencing the attitudes of patients and caregivers differently. The findings suggested that caregivers’ decisions were likely to be influenced by the burden of caregiving roles and the financial costs related to care for SCD. Patients were more likely to accept the therapies if provided with information on safety of the therapies and transparency of data from treated patients.

Conclusion

In preparation for GT trials or transplants, tailored engagement strategies for patients younger than 18 years old will be necessary as the majority of SCD patients in Africa are children. Healthcare professionals must be well informed to address questions and concerns from patients’ families. Overall, the study highlighted strong interest in curative therapies for SCD in Tanzania while identifying important factors shaping acceptability, underscoring the need for tailored engagement and early involvement of affected families in program planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellPatient Acceptance of Health CareHumansTanzaniaFemaleAdultMaleYoung AdultCaregiversHematopoietic Stem Cell TransplantationGenetic TherapyFocus GroupsHealth Knowledge, Attitudes, PracticeAdolescentQualitative Research

Stichwörter der Autor:innen

AcceptabilityCurative therapiesGene therapyHematopoietic stem cell transplantSickle cell disease

Autor:innen und Institutionen

  • Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, dbukini1@jh.edu.
  • Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Novartis Biomedical Research, Cambridge, Massachusetts, USA.

Förderung

  • Bill & Melinda Gates Foundation

Zitieren

APA

Bukini, D., Kassim, K., Kanza, C., Rifai, A., Chanzi, R., Amando, A., Amin, E., Spector, J., & Makani, J. (2026). “I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania. Public Health Genomics, 29(1), 257-268. https://doi.org/10.1159/000551690

Vancouver

Bukini D, Kassim K, Kanza C, Rifai A, Chanzi R, Amando A, et al. “I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania. Public Health Genomics. 2026;29(1):257-268. doi:10.1159/000551690

BibTeX
@article{Bukini2026,
  author = {Bukini, Daima and Kassim, Kassim and Kanza, Collins and Rifai, Aisha and Chanzi, Rahma and Amando, Augostino and Amin, Elianna and Spector, Jonathan and Makani, Julie},
  title = {“I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania},
  journal = {Public Health Genomics},
  year = {2026},
  volume = {29},
  number = {1},
  pages = {257--268},
  doi = {10.1159/000551690}
}
Kostenlos starten →